Excessive use of digital devices and mental health issues can both contribute to the development of dry eye syndrome.

The FDA has set back Aldeyra Therapeutics’ ambitions to win approval for its dry eye disease, rejecting its second ...

The FDA has asked for another well-controlled trial to establish the efficacy of reproxalap in dry eye disease.

The topical ocular drug is an investigational new drug candidate that requires more well-controlled studies to establish ...

Miebo produced substantial symptom relief in patients with dry eye disease during the first day and succeeding weeks of ...

The FDA rejected Aldeyra's resubmission for reproxalap, citing efficacy concerns. The company plans another trial and aims to ...

Aldeyra received a Complete Response Letter from the U.S. Food and Drug Administration (FDA) for the resubmission of the NDA ...

Blepharitis and dry eye syndrome both result in eye discomfort. They share similar symptoms but are different conditions. Blepharitis is eyelid inflammation often accompanied by crusts at the base ...

E ver since I became a contact lens wearer many years ago, chronic dry eyes and I have become fast and familiar friends. That ...

The latter, formerly an idol in one of Asia's top boy bands Smap in the 1990s, retired in January this year. According to media reports, a nearly 300-page report from the probe revealed the woman ...